Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Clinical trial NCT01794182 · COMPLETED
Trial details
- NCT number
- NCT01794182
- Sponsor
- Remedy Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-13
- Primary completion
- 2016-04-04
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.